Project Number 5P50AG005681-31 Agency/Funding Organization NIA Funding Year 2014 View Full Project Details for APOE METABOLISM IN AD AND CONTROLS Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 4. ApoE and Lipid Neurobiology a. ApoE in Abeta-Mediated AD Pathogenesis Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator MORRIS, JOHN Principal Investigator First Name JOHN Principal Investigator Last Name MORRIS Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-10-002: ALZHEIMER'S DISEASE RESEARCH CENTERS (P50) FY Overall Cost $190,040 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PHELPS, CREIGHTON H. Related Resources Repository National Alzheimer's Coordinating Center (NACC) [AlzPED] ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models [AlzPED] Estrogen Therapy Fails to Alter Amyloid Deposition in the PDAPP Model of Alzheimer’s Disease Clinical Trial Modulation of CSF Amyloid-beta Concentrations Via Behavioral Sleep Deprivation and Pharmacological Sleep Induction Pagination Previous page ‹‹ Page 2
